HealthAsianet Newsable
HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed ‘More Qualified And Less Conflicted’
in5points
HIMS stock snapped a 3-day losing streak after FDA added 8 new peptide voters to its advisory panel.
New panelists are deemed more qualified and less conflicted than previous members.
Expertise includes neurology, pain, dermatology, gastroenterology, addiction, cancer pharmacology, and patient advocacy.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically